Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease

Journal of Rheumatology

Volumn 27, Issue 3, 2000, Pages 810-813

  Moseley, Althea C ^c   Lindsley, Herbert B ^b   Skikne, Barry S ^c   Tawfik, Ossama ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c NONE

Author keywords

Epstein Barr virus; Hodgkin's disease; Human herpes virus 4; Juvenile rheumatoid arthritis; Lymphoproliferative disorders; Methotrexate; Rheumatoid arthritis

Indexed keywords

METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG SAFETY; FEMALE; HODGKIN DISEASE; HUMAN; LYMPHADENOPATHY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPLENOMEGALY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; METHOTREXATE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; VIRUS ACTIVATION;

EID: 0034056460     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sany J, Anaya JM, Lussiez V, Couret M, Combe B, Daures J-P. Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases. J Rheumatol 1991;18:1323-7.
2. Kremer JM, Phelps CT. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum 1992;35:138-45.
3. Tugwell P, Bennett K, Gent M. Methotrexate in rheumatoid arthrtis - Indications, contraindications, efficacy and safety. Ann Intern Med 1987;107:358-66.
4. Kamel OW, van de Rijn M, Hanasono MM. Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. Leuk Lymphoma 1995;16:363-8.
5. Londino AV Jr, Blatt J, Knisely AS. Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate. J Rheumatol 1998;25:1245-6.
6. Ferraccioli GF, Casatta L, Bartoli E, et al. Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. Arthritis Rheum 1995;38:867-8.
7. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996;14:1943-9.
8. Kamel OW, Weiss LM, van de Rijn M, Colby TV, Kingma DW, Jaffe ES. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol 1996;10:1279-87.
9. Kanegane H, Shintani N, Miyamori C. Peripheral blood lymphocyte subpopulations in three infants with hepatosplenomegaly caused by cytomegalovirus. Acta Paediatr Jpn 1995;37:370-3.
10. Flomenberg P, Piaskowski V, Harb J. Spontaneous, persistent infection of a B-cell lymphoma with adenovirus. J Med Virol 1996;48:267-72.
11. Basgoz N, Presky DH. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am 1995;9:901-23.
12. Luppi M, Torelli G. The new lymphotrophic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C in human lymphoproliferative diseases: an overview. Haematologica 1996;81:265-81.
13. Tesch H, Diehl V. Hodgkin's disease: from basic science to clinical application. Leukemia 1996;10 suppl 2:S74-S77.
14. Starzel TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984;1:583-7.
15. van de Rijn M, Cleary ML, Variakojis D, Warnke RA, Chang PP, Kamel OW. Epstein-Barr virus clonality in lymphomas occurring in patients with rheum-atoid arthritis. Arthritis Rheum 1996;39:638-42.
16. Tosato G, Steinberg AD, Blaese RM. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Eng J Med 1981;305:1238-43.